Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis
Frontiers in Microbiology · 09.10.2024 · 15
DOI: 10.3389/fmicb.2024.1477836 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.10.2024. Verfasst von Negar Narimisa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Research Center, Iran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 656 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The emergence of resistance to colistin, the last resort for treating severe infections caused by Pseudomonas aeruginosa , poses a significant threat to public health. This meta-analysis aimed to investigate the prevalence of colistin resistance in clinical isolates of P. aeruginosa.
Method
A comprehensive search of MEDLINE (PubMed), Web of Science, and Scopus databases was conducted to identify relevant articles published until December 2023. Subsequently, a meta-analysis was performed using Stata software to examine the pooled prevalence of colistin resistance and to conduct subgroup analyses.
Results
A total of 619 studies were included in the meta-analysis, revealing a global prevalence of colistin resistance of 1% among all P. aeruginosa isolates. Furthermore, cystic fibrosis patients exhibited the highest resistance to colistin, with a prevalence of 7% among the examined diseases.
Conclusion
The increase in colistin resistance in P. aeruginosa in recent years from 2% (in the period of 2006–2010) to 5% (in the period of 2020–2023) underscores the need for implementing infection prevention programs, using appropriate treatment regimens, and disseminating comprehensive information on antimicrobial resistance patterns. These measures are crucial for addressing this growing public health concern.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbial Biotechnology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Disaster and Emergency Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Institute for Chemistry and Biology of the Marine Environment (ICBM), School of Mathematics and Science, Carl von Ossietzky Universität Oldenburg Ammerländer Heerstraße, Oldenburg, Germany.
Zitieren
APA
Narimisa, N., Keshtkar, A., Dadgar-Zankbar, L., Bostanghadiri, N., Far, Y. R., Shahroodian, S., Zahedi Bialvaei, A., & Razavi, S. (2024). Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1477836
Vancouver
Narimisa N, Keshtkar A, Dadgar-Zankbar L, Bostanghadiri N, Far YR, Shahroodian S, et al. Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1477836
BibTeX
@article{Narimisa2024,
author = {Narimisa, Negar and Keshtkar, Abbasali and Dadgar-Zankbar, Leila and Bostanghadiri, Narjess and Far, Yasaman Rouein and Shahroodian, Soheila and Zahedi Bialvaei, Abed and Razavi, Shabnam},
title = {Prevalence of colistin resistance in clinical isolates of Pseudomonas aeruginosa: a systematic review and meta-analysis},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1477836}
}
EUVIMED